Expression of CD44 standard and variant isoforms in parotid gland and parotid gland tumours

被引:14
作者
Franchi, A [1 ]
Moroni, M [1 ]
Paglierani, M [1 ]
Santucci, M [1 ]
机构
[1] Univ Florence, Sch Med, Dipartimento Patol Umana & Oncol, I-50134 Florence, Italy
关键词
CD44; parotid gland; parotid gland neoplasms;
D O I
10.1034/j.1600-0714.2001.300910.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
In this study, we investigated the distribution of the standard form of the CD44 (CD44s) cell adhesion molecule and of its v3 and v6 isoforms in samples of foetal and adult parotid gland tissue, in comparison with samples of parotid gland adenomas and carcinoma ex pleomorphic adenoma. Foetal parotid gland showed CD44s and CD44v3 expression in the peripheral small primordial ducts and acini, while CD44v6 was only focally expressed. Adult parotid gland tissue showed a similar distribution of CD44s and variants, with a predominant expression in acinar structures and a weaker expression at duct level. In parotid gland adenomas, a diffuse and intense expression of CD44s and variants 3 and 6 was observed only in pleomorphic adenomas, while expression of CD44s was prevalent in Warthin's tumour, myoepithelioma and oncocytoma. The malignant areas of carcinoma ex pleomorphic adenoma showed a markedly decreased expression of CD44v3 and CD44v6 in comparison with the adjacent pleomorphic adenoma component. In conclusion, the prevalent expression of CD44s and variants in pleomorphic adenoma in comparison with other adenomas may be related to the abundant extracellular matrix production present in these tumours, while loss of CD44v3 and CD44v6 associated with the onset of carcinoma ex pleomorphic adenoma could promote stromal invasion, eventually contributing to the development of distant metastases.
引用
收藏
页码:564 / 568
页数:5
相关论文
共 27 条
  • [1] CD44 IS THE PRINCIPAL CELL-SURFACE RECEPTOR FOR HYALURONATE
    ARUFFO, A
    STAMENKOVIC, I
    MELNICK, M
    UNDERHILL, CB
    SEED, B
    [J]. CELL, 1990, 61 (07) : 1303 - 1313
  • [2] CD44 variant 6 (CD44v6) expression as a progression marker in benign, premalignant and malignant oral epithelial tissues
    Bahar, R
    Kunishi, M
    Kayada, Y
    Yoshiga, K
    [J]. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1997, 26 (06) : 443 - 446
  • [3] BASAL MEMBRANE-ASSOCIATED SUBSTANCES IN HUMAN SALIVARY-GLANDS AND SALIVARY-GLAND TUMORS
    CASELITZ, J
    SCHMITT, P
    SEIFERT, G
    WUSTROW, J
    SCHUPPAN, D
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 1988, 183 (04) : 386 - 394
  • [4] BASAL LAMINA OF EMBRYONIC SALIVARY EPITHELIA - NATURE OF GLYCOSAMINOGLYCAN AND ORGANIZATION OF EXTRACELLULAR MATERIALS
    COHN, RH
    BANERJEE, SD
    BERNFIELD, MR
    [J]. JOURNAL OF CELL BIOLOGY, 1977, 73 (02) : 464 - 478
  • [5] FOX SB, 1994, CANCER RES, V54, P4539
  • [6] IMMUNOLOCALIZATION OF ALPHA(2), ALPHA(5), AND ALPHA(6) INTEGRIN SUBUNITS IN SALIVARY TISSUE AND ADENOMAS OF THE PAROTID-GLAND
    FRANCHI, A
    SANTORO, R
    PAGLIERANI, M
    BONDI, R
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1994, 23 (10) : 457 - 460
  • [7] Comparison of integrin alpha chain expression in benign and malignant salivary gland tumors
    Franchi, A
    Santoro, R
    Paglierani, M
    Bondi, R
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1997, 83 (05): : 588 - 595
  • [8] Gakunga P, 1997, DEVELOPMENT, V124, P3987
  • [9] GNEPP DR, 1993, PATHOL ANNU, V28, P279
  • [10] Gunthert U, 1993, Curr Top Microbiol Immunol, V184, P47